ReWalk Robotics Ltd. (NASDAQ:RWLK) saw unusually-high trading volume on Friday . Approximately 52,900 shares were traded during trading, a decline of 5% from the previous session’s volume of 55,701 shares.The stock last traded at $7.08 and had previously closed at $7.02.

Several research firms have issued reports on RWLK. Zacks Investment Research raised shares of ReWalk Robotics from a “sell” rating to a “hold” rating in a report on Thursday, April 28th. Jefferies Group reissued a “buy” rating and set a $16.00 price objective on shares of ReWalk Robotics in a report on Sunday, May 8th. Finally, Piper Jaffray Cos. initiated coverage on shares of ReWalk Robotics in a report on Friday. They set an “overweight” rating and a $10.00 price objective on the stock. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $12.80.

The firm’s market capitalization is $86.97 million. The stock’s 50-day moving average price is $6.96 and its 200-day moving average price is $9.24.

ReWalk Robotics (NASDAQ:RWLK) last released its earnings results on Thursday, May 5th. The medical device company reported ($0.48) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.60) by $0.12. The company earned $2.06 million during the quarter, compared to analysts’ expectations of $1.56 million. During the same quarter in the previous year, the firm posted ($0.48) earnings per share. ReWalk Robotics’s revenue for the quarter was up 224.6% compared to the same quarter last year. Analysts anticipate that ReWalk Robotics Ltd. will post ($2.11) EPS for the current fiscal year.

In related news, Director Wayne Weisman sold 19,060 shares of the business’s stock in a transaction that occurred on Friday, June 3rd. The shares were sold at an average price of $7.89, for a total value of $150,383.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Scp Vitalife Partners (Israel) sold 4,772 shares of the business’s stock in a transaction that occurred on Friday, June 3rd. The shares were sold at an average price of $7.89, for a total transaction of $37,651.08. The disclosure for this sale can be found here.

A hedge fund recently bought a new stake in ReWalk Robotics stock. EAM Investors LLC purchased a new stake in shares of ReWalk Robotics Ltd. (NASDAQ:RWLK) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 93,333 shares of the medical device company’s stock, valued at approximately $1,351,000. EAM Investors LLC owned about 0.77% of ReWalk Robotics as of its most recent SEC filing.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.